fda glp-1 compounding crackdown october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of National Hispanic Medical Association |

Amongst the current treatments for diabetes are incretin therapies which are based on hormones called incretins, released from the gut after we eat

The goal is to support overall health, preserve muscle mass, reduce side effects, and ensure youre getting adequate nutrition

For instance, some Blue Cross Blue Shield plans may ask for prior authorization, which means your healthcare provider will need to submit documentation to justify the prescription

Yet, some patients may not want to stay on injectable versions of GLP-1 weight loss drugs, such as semaglutide and tirzepatide, long term

Peptide hormones like GLP-1 are relatively large and structurally complex molecules

Clinical data shows that approximately 5% of tirzepatide users and a slightly higher percentage of semaglutide users experience noticeable hair loss